O'Dell Group, LLC Gilead Sciences, Inc. Transaction History

O'Dell Group, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 15, 2024	BUY	$73.27 - $83.09 $61,107 - $69,297	834 New	834 $67,000
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $63,012 - $71,874	829 New	829 $63,000
Q3 2022 Nov 08, 2022	BUY	$59.54 - $68.01 $178 - $204	3 Added 0.37%	823 $51,000
Q2 2022 Aug 11, 2022	BUY	$57.72 - $65.01 $173 - $195	3 Added 0.37%	820 $51,000
Q1 2022 May 05, 2022	BUY	$57.92 - $72.58 $173 - $217	3 Added 0.37%	817 $49,000
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $129 - $147	2 Added 0.25%	814 $59,000
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $54,964 - $59,300	812 New	812 $57,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of O'Dell Group, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Dell Group, LLC with notifications on news.